ACT Capital Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $127K | Hold |
9,950
| – | – | 0.18% | 46 |
|
|
2022
Q2 | $205K | Hold |
9,950
| – | – | 0.29% | 41 |
|
|
2022
Q1 | $374K | Sell |
9,950
-675
| -6% | -$25.4K | 0.4% | 38 |
|
|
2021
Q4 | $1.02M | Sell |
10,625
-1,325
| -11% | -$128K | 0.74% | 29 |
|
|
2021
Q3 | $1.73M | Hold |
11,950
| – | – | 0.9% | 25 |
|
|
2021
Q2 | $2.21M | Buy |
+11,950
| New | +$2.21M | 1.13% | 18 |
|